eISSN 2508-3589
pISSN 2508-1926

Table. 1.

Table. 1.

Characteristics of patients with diabetic papillopathy

Case 1 Case 2 Case 3
Systemic
Age 51 64 71
Sex F M M
Diabetes treatment Oral medication + Insulin Oral medication Oral medication
Duration of diabetes (years) 15 20 16
Laterality Both eye Right Right
Ocular, before diabetic papillopathy
Diabetic retinopathy Severe NPDR Not checked Regressed PDR
Cup-to-disc diameter ratio, before presentation or from contralateral eye, right eye/left eye 0.25/0.26 0.21 0.3
Best-corrected visual acuity, right eye/left eye Not checked Not checked Not checked
HbA1c level 16.8 Not checked Not checked
Ocular, at presentation of diabetic papillopathy
Diabetic retinopathy Active PDR Moderate NPDR Regressed PDR
Best-corrected visual acuity, decimal, right eye/left eye 0.1/0.08 0.16/0.63 0.2/0.5
Macular edema +/+ + +
HbA1c level (%) 10.9 9.3 10.6
Recent insulin use + - -
Creatine level (mg/dL) 0.78 0.66 5.65
eGFR (MDRD) (mL/min/1.73 m2) 79.5 121.5 10.03
Urine protein (mg/dL) 612.9 48.5 351.5
Treatment
Intravitreal bevacizumab injection +/+ ++ -
Panretinal Photocoagulation +/+ - -
Sub-Tenon Triamcinolone injection +++/+ - +
Intravitreal Triamcinolone injection -/++ - -
Interval from onset to regression of papilledema (months) 6/6 5 2
Ocular, at final follow-up
Interval between presentation and latest follow-up (months) 48 11 48
Optic disc appearance Pale/pale Not pale Not pale
Best-corrected visual acuity, right eye/left eye 0.06/0.125 FC 50 cm/0.63 0.25/0.5

F = female; M = male; PDR = proliferative diabetic retinopathy; eGFR = estimated glomerular filtration rate; MDRD = modification of diet in renal disease; FC = finger count.

J Retin 2021;6:162-70 https://doi.org/10.21561/jor.2021.6.2.162
© 2021 J Retin